Xolair (omalizumab) Powder for Injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) December 2015 WARNINGS AND PRECAUTIONS Anaphylaxis A case-control study showed that, among Xolair users, patients with a history...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts